The use of a novel single-cell sequencing technology, Drop-Seq, to unravel tumour heterogeneity and identify potential chemoresistant cells in high-grade serous ovarian cancer (HGSOvCa)

Project Details

Short titleThe use of a novel single-cell sequencing technology, Drop-Seq, to unravel tumour heterogeneity and identify potential chemoresistant cells in high-grade serous ovarian cancer (HGSOvCa)
StatusFinished
Effective start/end date1/06/18 → 31/05/19

Funding

  • WELLBEING OF WOMEN